[Management of postoperative pain in stomatology with ibuprofen L-arginine and naproxen]
- PMID: 9738364
[Management of postoperative pain in stomatology with ibuprofen L-arginine and naproxen]
Abstract
Background: The aim of this prospective, randomized study is to compare the efficacy and safety of ibuprofen L-arginine and naproxen in the treatment of postoperative dental pain.
Methods: Seventy patients undergoing removal of impacted third molars were randomly allocated to receive 4 hours after surgery a single oral dose of either ibuprofen L-arginine 400 mg or naproxen 550 mg. Ten patients dropped out from the study because they took the study drug before the allowed time. Using a self-rating record, patients rated their pain and its relief for 1 hour after the drug administration. Remedication, if needed, and mean time of remedication were also recorded.
Results: A statistically significant reduction in pain scores with respect to the baseline values was recorded 5 minutes and 15 minutes after the drug administration in the ibuprofen L-arginine and in the naproxen-treated group, respectively. The summed pain intensity difference (SPID) over 60 minutes resulted significantly higher in the ibuprofen L-arginine than in the naproxen-treated group. A complete abolition of pain 60 minutes after medication was obtained in 12/28 patients (42.9%) in the ibuprofen L-arginine and in 5/32 patients (15.6%) in the naproxen-treated group, respectively (p = 0.04). Number of patients requiring remedication, mean time of remedication and drug related adverse effects did not significantly differ in the two treatment group.
Conclusions: Global evaluation of the drugs by the patients showed ibuprofen more effective drug than naproxen.
Similar articles
-
Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.Clin Ther. 2006 Sep;28(9):1279-95. doi: 10.1016/j.clinthera.2006.09.015. Clin Ther. 2006. PMID: 17062301 Clinical Trial.
-
Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.Clin Ther. 2005 Apr;27(4):418-29. doi: 10.1016/j.clinthera.2005.04.010. Clin Ther. 2005. PMID: 15922815 Clinical Trial.
-
The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.Int J Clin Pharmacol Res. 1998;18(1):21-9. Int J Clin Pharmacol Res. 1998. PMID: 9604731 Clinical Trial.
-
Naproxen: pharmacology and dental therapeutics.J Can Dent Assoc. 1992 May;58(5):401-5. J Can Dent Assoc. 1992. PMID: 1628263 Review.
-
New peripherally-acting oral analgesic agents.Annu Rev Pharmacol Toxicol. 1983;23:617-47. doi: 10.1146/annurev.pa.23.040183.003153. Annu Rev Pharmacol Toxicol. 1983. PMID: 6347055 Review. No abstract available.
Cited by
-
Single dose oral naproxen and naproxen sodium for acute postoperative pain.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004234. doi: 10.1002/14651858.CD004234.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004234. doi: 10.1002/14651858.CD004234.pub3. PMID: 15495091 Free PMC article. Updated.
-
Ibuprofen for acute postoperative pain in children.Cochrane Database Syst Rev. 2024 Jan 5;1(1):CD015432. doi: 10.1002/14651858.CD015432.pub2. Cochrane Database Syst Rev. 2024. PMID: 38180091 Free PMC article.